Skip to main content
Erschienen in: Calcified Tissue International 1/2016

22.02.2016 | Original Research

Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis

verfasst von: Cristian Caimmi, Paola Caramaschi, Giovanni Barausse, Giovanni Orsolini, Luca Idolazzi, Davide Gatti, Ombretta Viapiana, Silvano Adami, Domenico Biasi, Maurizio Rossini

Erschienen in: Calcified Tissue International | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate in a large size cohort of SSc patients bone mineral density (BMD) and to analyze its possible determinants. 106 consecutive outpatients affected by SSc were enrolled and completely evaluated for bone metabolism and SSc characteristics. For the statistical analysis, we preferred Z score to BMD or T score since the population was composed of patients of different ages and of both sexes. Mean neck Z score was significantly lower than 0. No significant differences were found for other sites. Female patients were shown to have a total femur and neck Z score significantly lower than 0 (p = 0.028 and p < 0.001, respectively). 13 % of patients had at least one morphometric non-clinical vertebral fracture. In univariate analysis, total femur Z score was lower in female (p = 0.050) and positively correlates with BMI (p = 0.001), neck Z score positively correlates with age (p = 0.016), and whole body Z score positively correlates with BMI (p < 0.001). No correlations were found for lumbar Z score. The multivariate analysis confirmed the positive correlation between BMI and total femur and whole body Z score and between age and neck femur Z score (p = 0.005, p < 0.001 and p = 0.040, respectively). Lung involvement was shown to correlate with a lower whole body Z score in multivariate analysis (p = 0.037). We found a modest risk of low BMD in patients with SSc and the important protective role of BMI. Patients with lung involvement showed lower whole body Z score.
Literatur
1.
Zurück zum Zitat Omair MA, Pagnoux C, McDonald-Blumer H, Johnson SR (2013) Low bone density in systemic sclerosis: a systematic review. J Rheumatol 40:1881–1890CrossRefPubMed Omair MA, Pagnoux C, McDonald-Blumer H, Johnson SR (2013) Low bone density in systemic sclerosis: a systematic review. J Rheumatol 40:1881–1890CrossRefPubMed
3.
4.
Zurück zum Zitat Antonelli A, Ferri C, Fallahi P, Cazzato M, Ferrari SM, Sebastiani M et al (2007) Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 156:431–437CrossRefPubMed Antonelli A, Ferri C, Fallahi P, Cazzato M, Ferrari SM, Sebastiani M et al (2007) Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. Eur J Endocrinol 156:431–437CrossRefPubMed
5.
Zurück zum Zitat Kucharz EJ (1993) Thyroid disorders in patients with progressive systemic sclerosis: a review. Clin Rheumatol 12:159–161CrossRefPubMed Kucharz EJ (1993) Thyroid disorders in patients with progressive systemic sclerosis: a review. Clin Rheumatol 12:159–161CrossRefPubMed
6.
Zurück zum Zitat Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRef
7.
Zurück zum Zitat LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
8.
Zurück zum Zitat Akesson A, Fiori G, Krieg T, van den Hoogen FHJ, Seibold JR (2003) Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 21(3 Suppl 29):s5–s8PubMed Akesson A, Fiori G, Krieg T, van den Hoogen FHJ, Seibold JR (2003) Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 21(3 Suppl 29):s5–s8PubMed
9.
Zurück zum Zitat Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4:368–381CrossRefPubMed Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4:368–381CrossRefPubMed
10.
Zurück zum Zitat Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160PubMed
11.
Zurück zum Zitat La Montagna G, Vatti M, Valentini G, Tirri G (1991) Osteopenia in systemic sclerosis: evidence of a participating role of earlier menopause. Clin Rheumatol 10:18–22CrossRefPubMed La Montagna G, Vatti M, Valentini G, Tirri G (1991) Osteopenia in systemic sclerosis: evidence of a participating role of earlier menopause. Clin Rheumatol 10:18–22CrossRefPubMed
12.
Zurück zum Zitat La Montagna G, Baruffo A, Abbadessa S, Maja L, Tirri R (1995) Evidence for bone resorption in systemic sclerosis. J Rheumatol 22:797–799PubMed La Montagna G, Baruffo A, Abbadessa S, Maja L, Tirri R (1995) Evidence for bone resorption in systemic sclerosis. J Rheumatol 22:797–799PubMed
13.
Zurück zum Zitat Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A et al (2004) Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. Clin Exp Rheumatol 22:313–318PubMed Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A et al (2004) Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. Clin Exp Rheumatol 22:313–318PubMed
14.
Zurück zum Zitat Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A et al (2004) Bone mineral density in patients with systemic sclerosis. Ann Rheum Dis 63:326–327CrossRefPubMedPubMedCentral Frediani B, Baldi F, Falsetti P, Acciai C, Filippou G, Spreafico A et al (2004) Bone mineral density in patients with systemic sclerosis. Ann Rheum Dis 63:326–327CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Carbone L, Tylavsky F, Wan J, McKown K, Cheng S (1999) Bone mineral density in scleroderma. Rheumatology 38:371–372CrossRefPubMed Carbone L, Tylavsky F, Wan J, McKown K, Cheng S (1999) Bone mineral density in scleroderma. Rheumatology 38:371–372CrossRefPubMed
16.
Zurück zum Zitat Di Munno O, Mazzantini M, Massei P, Ferdeghini M, Pitaro N, Latorraca A et al (1995) Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 14:407–412CrossRefPubMed Di Munno O, Mazzantini M, Massei P, Ferdeghini M, Pitaro N, Latorraca A et al (1995) Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 14:407–412CrossRefPubMed
17.
Zurück zum Zitat Dovio A, Data V, Carignola R, Calzolari G, Vitetta R, Ventura M et al (2008) Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis. J Rheumatol 35:2206–2213CrossRefPubMed Dovio A, Data V, Carignola R, Calzolari G, Vitetta R, Ventura M et al (2008) Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis. J Rheumatol 35:2206–2213CrossRefPubMed
18.
Zurück zum Zitat Sampaio-Barros PD, Costa-Paiva L, Filardi S, Sachetto Z, Samara AM, Marques-Neto JF (2005) Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 23:180–184PubMed Sampaio-Barros PD, Costa-Paiva L, Filardi S, Sachetto Z, Samara AM, Marques-Neto JF (2005) Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol 23:180–184PubMed
19.
Zurück zum Zitat Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35:384–387CrossRefPubMed Souza RB, Borges CT, Takayama L, Aldrighi JM, Pereira RM (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35:384–387CrossRefPubMed
20.
Zurück zum Zitat Yuen SY, Rochwerg B, Ouimet J, Pope JE (2008) Patients with scleroderma may have increased risk of osteoporosis: a comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions. J Rheumatol 35:1073–1078PubMed Yuen SY, Rochwerg B, Ouimet J, Pope JE (2008) Patients with scleroderma may have increased risk of osteoporosis: a comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions. J Rheumatol 35:1073–1078PubMed
21.
Zurück zum Zitat Neumann K, Wallace DJ, Metzger AL (2000) Osteoporosis-less than expected in patients with scleroderma? J Rheumatol 27:1822–1823PubMed Neumann K, Wallace DJ, Metzger AL (2000) Osteoporosis-less than expected in patients with scleroderma? J Rheumatol 27:1822–1823PubMed
22.
Zurück zum Zitat da Silva HC, Szejnfeld VL, Assis LS, Sato EI (1997) Study of bone density in systemic scleroderma. Rev Assoc Med Bras 43:40–46PubMed da Silva HC, Szejnfeld VL, Assis LS, Sato EI (1997) Study of bone density in systemic scleroderma. Rev Assoc Med Bras 43:40–46PubMed
23.
Zurück zum Zitat Wan YN, Zhang L, Wang YJ, Yan JW, Wang BX, Wang J (2014) The association between systemic sclerosis and bone mineral density: a meta-analysis of observational studies. Int J Rheum Dis 17:845–855CrossRefPubMed Wan YN, Zhang L, Wang YJ, Yan JW, Wang BX, Wang J (2014) The association between systemic sclerosis and bone mineral density: a meta-analysis of observational studies. Int J Rheum Dis 17:845–855CrossRefPubMed
24.
Zurück zum Zitat O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European vertebral osteoporosis study. J Bone Miner Res 11:1010–1018CrossRefPubMed O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European vertebral osteoporosis study. J Bone Miner Res 11:1010–1018CrossRefPubMed
25.
Zurück zum Zitat Lai CC, Wang SH, Chen WS, Liu TJ, Lee PC, Chang YS (2015) Increased risk of osteoporotic fractures in patients with systemic sclerosis: a nationwide population-based study. Ann Rheum Dis 74:1347–1352CrossRefPubMed Lai CC, Wang SH, Chen WS, Liu TJ, Lee PC, Chang YS (2015) Increased risk of osteoporotic fractures in patients with systemic sclerosis: a nationwide population-based study. Ann Rheum Dis 74:1347–1352CrossRefPubMed
26.
Zurück zum Zitat Atteritano M, Sorbara S, Bagnato G, Miceli G, Sangari D, Morgante S et al (2013) Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS One 8:e66991CrossRefPubMedPubMedCentral Atteritano M, Sorbara S, Bagnato G, Miceli G, Sangari D, Morgante S et al (2013) Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS One 8:e66991CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Avouac J, Koumakis E, Toth E, Meunier M, Maury E, Kahan A et al (2012) Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Arthritis Care Res (Hoboken) 64:1871–1878CrossRef Avouac J, Koumakis E, Toth E, Meunier M, Maury E, Kahan A et al (2012) Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Arthritis Care Res (Hoboken) 64:1871–1878CrossRef
28.
Zurück zum Zitat Naylor K, Eastell R (2012) Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol 8:379–389CrossRefPubMed Naylor K, Eastell R (2012) Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol 8:379–389CrossRefPubMed
29.
Zurück zum Zitat Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420CrossRefPubMed Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420CrossRefPubMed
30.
Zurück zum Zitat Silverber SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D et al (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4:283–291CrossRef Silverber SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D et al (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4:283–291CrossRef
31.
Zurück zum Zitat LoCascio V, Bonucci E, Imbimbo B, Ballanti P, Tartarotti D, Galvanini G et al (1984) Bone loss after glucocorticoid therapy. Calcif Tissue Int 36:435–438CrossRef LoCascio V, Bonucci E, Imbimbo B, Ballanti P, Tartarotti D, Galvanini G et al (1984) Bone loss after glucocorticoid therapy. Calcif Tissue Int 36:435–438CrossRef
32.
Zurück zum Zitat Civitelli R, Ziambaras K (2008) Epidemiology of glucocorticoid-induced osteoporosis. J Endocrinol Investig 31:2–6 Civitelli R, Ziambaras K (2008) Epidemiology of glucocorticoid-induced osteoporosis. J Endocrinol Investig 31:2–6
33.
Zurück zum Zitat Tu X, Rhee Y, Condon KW, Bivi N, Allen MR, Dwyer D et al (2012) Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone 50:209–217CrossRefPubMedPubMedCentral Tu X, Rhee Y, Condon KW, Bivi N, Allen MR, Dwyer D et al (2012) Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone 50:209–217CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Rossini M, Gatti D, Adami S (2013) Involvement of WNT/beta-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93:121–132CrossRefPubMed Rossini M, Gatti D, Adami S (2013) Involvement of WNT/beta-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93:121–132CrossRefPubMed
35.
Zurück zum Zitat Caramaschi P, Dalla Gassa A, Ruzzenente O, Volpe A, Ravagnani V, Tinazzi I et al (2010) Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol 29:1419–1425CrossRefPubMed Caramaschi P, Dalla Gassa A, Ruzzenente O, Volpe A, Ravagnani V, Tinazzi I et al (2010) Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol 29:1419–1425CrossRefPubMed
36.
Zurück zum Zitat Arnson Y, Amital H, Agmon-Levin N, Alon D, Sánchez-Castañón M, López-Hoyos M et al (2011) Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev 10:490–494CrossRefPubMed Arnson Y, Amital H, Agmon-Levin N, Alon D, Sánchez-Castañón M, López-Hoyos M et al (2011) Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev 10:490–494CrossRefPubMed
37.
Zurück zum Zitat Vacca A, Cormier C, Piras M, Mathieu A, Kahan A, Allanore Y (2009) Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 36:1924–1929CrossRefPubMed Vacca A, Cormier C, Piras M, Mathieu A, Kahan A, Allanore Y (2009) Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 36:1924–1929CrossRefPubMed
38.
Zurück zum Zitat Ionescu AA, Schoon E (2003) Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:64s–75sCrossRefPubMed Ionescu AA, Schoon E (2003) Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl 46:64s–75sCrossRefPubMed
39.
Zurück zum Zitat Tschopp O, Boehler A, Speich R, Weder W, Seifert B, Russi EW et al (2002) Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant 2:167–172CrossRefPubMed Tschopp O, Boehler A, Speich R, Weder W, Seifert B, Russi EW et al (2002) Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease. Am J Transplant 2:167–172CrossRefPubMed
Metadaten
Titel
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis
verfasst von
Cristian Caimmi
Paola Caramaschi
Giovanni Barausse
Giovanni Orsolini
Luca Idolazzi
Davide Gatti
Ombretta Viapiana
Silvano Adami
Domenico Biasi
Maurizio Rossini
Publikationsdatum
22.02.2016
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 1/2016
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-016-0119-5

Weitere Artikel der Ausgabe 1/2016

Calcified Tissue International 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.